News

Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...
Neha Anand, Analyst, Biopharma Intelligence Services, Citeline, explains how the approval of Embrelis marks a pivotal moment ...
Gov. Glenn Youngkin says he has a deal for a multi-billion-dollar pharmaceutical factory in Virginia, but he doesn't have a ...
Pharmaceutical marketers in Lagos yesterday protested the alleged hijack of the Coordinated Wholesale Centre (CWC) project by ...
A functional precision medicine platform intends to streamline cancer treatment by matching patients against a battery of FDA ...
The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
Pharmaceutical giant Eli Lilly delivers strong financial results and has a deep lineup and pipeline. Much smaller Viking Therapeutics boasts several candidates whose progress could jolt its shares.
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
The HHS secretary and four of his advisers earned at least $3.2 million from their work opposing Big Pharma and promoting ...
The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...
Doing more physical activities throughout the week is a known way to improve sleep, but new research shows you don't have to ...
President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.